The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
Researchers at Brigham and Women’s Hospital have developed a nasal spray that could provide broad-spectrum protection against ...
The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.